Drug Type Small molecule drug |
Synonyms QC6352 |
Target |
Mechanism KDM4 inhibitors(lysine demethylase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H25N3O2 |
InChIKeyXSMABFRQESMONQ-SFHVURJKSA-N |
CAS Registry1851373-36-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 02 Aug 2017 | |
Breast Cancer | Preclinical | IT | 02 Aug 2017 | |
Colonic Cancer | Preclinical | US | 02 Aug 2017 | |
Colonic Cancer | Preclinical | IT | 02 Aug 2017 |